PROFILAKTIKA RETsIDIVIRUYuShchIKh INFEKTsIY NIZhNIKh MOChEVYVODYaShchIKh PUTEYVZGLYaD IZ PROShLOGO V BUDUShchEE
- Authors: Sinyakova L.A.1, Shteynberg M.L.1
-
Affiliations:
- Issue: No 4 (2012)
- Pages: 83-87
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/279558
- ID: 279558
Cite item
Open Access
Access granted
Abstract
Full Text
References
- Foxman B. Am J Public Health 1990; 80:331-333.
- Naber K. G., Bergman B., Bjerklund-Johansen T. E. et al. Guidelines on urinary and male genital tract infections. In: EAU Guidelines. Edition presented at the 16 th EAU Congress, Geneva, Switzerland, 2001.
- Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001). Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. [access date January 2011] http://www.cebm.net/ index.aspx?o=1025
- Naber K. G. Adv Clin Exp Med 1998; 7: 41-46.
- Dwyer P. L., O'Reilly M. Recurrent urinary tract infection in the female. Curr. Opin. Obstet. Gynecol. 2002; 14(5): 537-543.
- Albert X., Huertas I., Pereiró II. et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004(3):CD001209.
- Hooton T. M. Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents. 2001;17(4):259-268.
- Schaeffer A. J., Stuppy B. A. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J. Urol. 1999;161(1):207-211. http://www.ncbi.nlm.nih.gov/pubmed/10037399
- Marchese A., Bozzolasco M., Gualco L. et al. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int. J. Antimicrob. Agents. 2003; 22 Suppl. 2:95-100.
- Guidelines on urological infections. Guidelines European Association of Urology, 2011.
- Bauer H. W., Rahlfs V. W., Lauener P. A. et al. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int. J. Antimicrob. Agents 2002;19(6):451-456.
- Naber K. G., Cho Y. H., Matsumoto T. et al. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int. J. Antimicrob. Agents. 2009;33(2):111-119.
- Guay D. R. P. Cranberry and urinary tract infections. Drugs. 2009: 69(7):775—807.
- Bailey D. T., Dalton C., Joseph Daugherty F. et al. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study. Phytomedicine 2007;14(4):237—241.
- Kontiokari T., Sundqvist K., Nuutinen M. et al. Randomised trial of cranberrylingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322(7302):1571.
- Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can. J. Urol. 2002;9(3):1558-1562.
- Jepson R., Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008; (1): CD001321.
- DiMartino P., Agniel R., David K. et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: double-blind randomized placebo-controlled crossover trial. World J Urol, 2006. 24(1):21—27.
- Marion E., McMurdo M., Argo I. et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J. Antimicrob Chemother. 2008; 63(2):1000—1008.
Supplementary files
